TLRY Archives - Page 6 of 9 - Blue Horseshoe Stocks

INO Update & More

Inovio Pharmaceuticals, Inc. INO

We signaled INO on Thursday morning, and this week, the stock has enjoyed some really solid activity, which facilitated the chance at a big gain for traders. We have observed a range of 3.83-7.48 in just a couple of sessions. That works out to total potential profit of 95%

It was a buck of the overall trend as many of these pharma plays have been doing through the coronavirus scare currently in progress. While the markets got a momentary boost from the Fed’s surprise rate cut yesterday, it was not long-lived, and the decline for other stocks continued throughout the majority of the session.

This morning, the stock has hit 8.80 in the premarket, extending our observed gain this week to 130%

While world governments rush to contain the spread of the virus, it would not yet be accurate to call it under control. We would expect much more hardship on the day-to-day for stocks before we’re out of the woods. So plays like INO are a welcome respite during this tumultuous time, and we’ll do our best to keep them coming.

Fresh Options Ideas
CPB Weekly $49-50.50 Calls
JWN Weekly $32.50-30 Puts

Extended Watchlist:
LLIT, NVNT, SPOM, TLRY, TOMZ

2019 Winners That Could Keep Running in 2020

FuelCell Energy, Inc. FCEL

For our first mention of the year, we are looking at FCEL, which ended up registering as the NASDAQ’s #1 daily gainer on New Year’s Eve. We’ve been tagging this one amid its recent push to new highs, but we actually began our coverage in October. (We always have receipts! You can view all of our reports containing a mention of this stock by clicking here.) The stock established its bottom shortly thereafter on Halloween, when it registered a low of .23.

FCEL had a productive fall and early winter, and on Tuesday, pushed to a brand new high of 2.75. That’s an unbelievable increase of 1096% in exactly two months’ time. Even if you only caught our more recent December 20th alert on FCEL after which the PPS low was .71, Tuesday’s high enabled gains of up to 272%

It was a great call to close out 2019, and we’re ready to tackle 2020 head-on! We won’t rule out the possibility of FCEL continuing its incredible uptrend, in fact, the stock has set another new high of 2.95 here in the premarket so far!

Other New Highs

We recently brought up ONCY and OWCP for their solid performances after we had placed them on watch, and both finished out 2019 by recording new highs as well!

Oncolytics Biotech, Inc. ONCY was coincidentally tagged in the same November report as FCEL, as well as several more recent mentions, if you check the tag in our archives. Just a couple of days following that November alert, ONCY saw a low of .82. On Tuesday its new high came in at 6.02, for a whopping gain of 634%
____

As for OWC Pharmaceutical Research Corp. OWCP, on Tuesday morning we were just heralding the spectacular progress it has made since our initial call at .028, and the stock once again made a multibag intraday surge to new highs to close out the year, hitting .09, and registering as an increase of 221%

Fresh Options Idea:
RAD 01/10 $16.50-18 Calls

Extended Watchlist:
TLRY, CGC, CRON, GEVO, SAVA, AKCA, AKRX (Bottom bouncer)

Blue Horseshoe Stocks: TLRY Recap & More

Tilray, Inc. TLRY

Our first order of business this morning is to just provide a quick recap of our successful options idea from Friday, which we did not provide yesterday due to the release of our Special Report on PASO.(Check that report out if you missed it)

In Friday’s newsletter, we submitted the TLRY Weekly $92.50-95 Calls as potential day-trade candidates, and every single contract in that range provided huge multi-bag gain opportunities!

$92.50 Calls – Range: 2.10-8.30 – Max Gain: 295%
$93 Calls – Range: 2.00-9.20 – Max Gain: 360%
$93.50 Calls – Range: 1.80-5.00 – Max Gain: 178%
$94 Calls – Range: 2.14-9.83 – Max Gain: 359%
$95 Calls – Range: 1.21-8.85 – Max Gain: 631%

OPKO Health, Inc. OPK – Review

The last time we signaled OPK for observation was just a few weeks ago, on December 28th, just as the stock was gapping up off of its annual lows. Following that report, we’ve seen a couple weeks of steady gains, in an overall range from 2.84-3.935. That represents a solid 39% increase, and a good start to the 2019 calendar year.

We’ve also observed CEO Phillip Frost purchasing 15,000 shares out of the open market yesterday, near those highs. The next step for OPK would be to make a run at its 200DMA of 4.12, so we’ll continue to keep it on our radar in the days and weeks ahead.

Extended Watchlist:
PASO, DTEA, FTNW, KTOV, CVM

Blue Horseshoe Stocks: Options Review & More

Options Review

Bed Bath & Beyond, Inc. BBBY – Yesterday morning’s premarket report contained an options idea for Bed Bath & Beyond following the company’s quarterly earnings report, the BBBY Weekly $13 & $13.50 Calls, and those plays both turned in fantastic intraday performances.

Regardless of which strike point was chosen, traders could have secured multi-bag profits on the day. The $13 Calls traded up from a low of .30 to a high of 1.30, for an increase of 333%, while the $13.50’s also crushed it with a huge 431% rip from .16-.85!
_______

Constellation Brands Inc. STZ –Just as Constellation stock got crushed to new lows in the premarket on Wednesday, we formulated a couple of longer-term options ideas, and wanted to provide updates on the activity there as well.

We were banking on STZ reversing off of those lows and beginning a recovery, and so far, it’s going quite well. Our targets were the the STZ 02/01 $150-157.50 Calls and the 04/18 $160-170 Calls, and all seven sets of contracts in those ranges have been good for significant gain opportunities. These remain in play, and will remain on our watchlist going forward.

02/01 $150-157.50 Calls
$150 Calls – Range: 8.80-11.50 – Max Gain: 31%
$152.50 Calls – Range: 3.80-6.70 – Max Gain: 76%
$155 Calls – Range: 2.90-8.00 – Max Gain: 176%
$157.50 Calls – Range: 3.00-6.65 – Max Gain: 122%

04/18 $160-170 Calls

$160 Calls – Range: 5.50-10.83 – Max Gain: 97%
$165 Calls – Range: 4.00-8.01 – Max Gain: 101%
$170 Calls – Range: 2.78-6.07 – Max Gain: 118%
_____

Fresh Ideas:
GM Weekly $36-37.50 Calls
TLRY Weekly $92.50-95 Calls

China SXT Pharma Inc SXTC

To wrap things up we wanted to go over the call we made on Monday morning in SXTC, which at the time had registered a low of 5.684. After steadily ramping up all week, yesterday the stock reached a new high of 23.35. That worked out to an incredible four-day swing of 311%

Cheers to anyone who caught this mover in Monday morning’s premarket report. It adds to an already impressive start for us here in 2019.

Extended Watchlist:
FTK, AQMS, MGEN, NAVB, SNSS, CFRX, TEUM

Blue Horseshoe Stocks: HSY Options & More

The Hershey Co. HSY

We’re looking at one of the biggest players in the Halloween candy game in Hershey as we kick off a fresh trading week. The company reported its Q3 earnings on Thursday, and despite a frosty reception from Wall Street, we are liking the look of this play.

The company asserts that it is on a good path, having had what the CEO calls a game changing year. While the stock did see its biggest daily loss since 2016 on Thursday following the report, it did not turn into a multi-day slide. Coupled with what looks to be another rebound day for the markets at large, and we’re interested in signaling a few HSY Calls.

We’ll place the HSY Weekly $102-104 Calls on watch this morning.

____

Bonus Idea:
Nutanix, Inc. NTNX 01/18 $42.50 & $45 Calls

SPDR S&P 500 ETF (SPY)

On Tuesday, we noted that with such a sharp and rapid downturn in the markets, that a rebound was certain to be in the cards for the SPY. It led us to signal interest in the SPY 10/31 $275-277 Calls, which will certainly be in play today as the SPY is gapping up big this morning in the premarket.

We’ll be back tomorrow morning with a recap of what is likely to be a cleanup session for these plays today.

Extended Watchlist:
DPW, ESES, XSPA, AKER, SBS, TLRY, AMRN, NXTD, STNE